Discontinuation report PMS-SULFASALAZINE-E.C. TAB 500MG
Report ID | 134853 |
Drug Identification Number | 00598488 |
Brand name | PMS-SULFASALAZINE-E.C. TAB 500MG |
Common or Proper name | SULFASALAZINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | SULFASALAZINE |
Strength(s) | 500MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | A07EC |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-02-28 |
Remaining supply date | 2021-02-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Demand transferred to 5760684882 pms-SULFASALAZINE-E.C. 500mg TABS 100 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-03-01 | English | Compare |
v2 | 2021-03-01 | French | Compare |
Showing 1 to 2 of 2